Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,122 | 4,780 | 5,164 | 6,166 | 6,840 |
| TOTAL | $5,068 | $5,354 | $5,477 | $6,588 | $7,028 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 314 | 314 | 1,018 |
| TOTAL | $N/A | $N/A | $314 | $314 | $1,018 |
| Total Assets | $5,068 | $5,354 | $5,791 | $6,901 | $8,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 578 | 347 | 240 | 284 | 243 |
| Accrued Expenses | 534 | 557 | 428 | 611 | 766 |
| TOTAL | $1,112 | $903 | $668 | $894 | $1,009 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,112 | $903 | $668 | $894 | $1,009 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,291 | 1,542 | 1,542 | 1,542 | 1,542 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -199,296 | -198,786 | -198,098 | -197,195 | -196,140 |
| Other shareholders' equity | -27 | -27 | -27 | -27 | -27 |
| TOTAL | $3,956 | $4,450 | $5,123 | $6,007 | $7,037 |
| Total Liabilities And Equity | $5,068 | $5,354 | $5,791 | $6,902 | $8,046 |